Today, an Insider at Iridex Corp (NASDAQ: IRIX), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT V, bought shares of IRIX for $420K.
Following this transaction PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT V’s holding in the company was increased by 5.6% to a total of $8.34 million. In addition to PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT V, one other IRIX executive reported Buy trades in the last month.
See today’s analyst top recommended stocks >>
Based on Iridex Corp’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $10.3 million and GAAP net loss of $3.28 million. In comparison, last year the company earned revenue of $10 million and had a GAAP net loss of $2.75 million. Currently, Iridex Corp has an average volume of 4,486.
Starting in November 2017, IRIX received 4 Buy ratings in a row.
The insider sentiment on Iridex Corp has been positive according to 16 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices and consumable instrumentation for the ophthalmology market. Its products include lasers, laser delivery and glaucoma devices, retinal surgical instruments, veterinary, and ENT. The company was founded by Eduardo Arias, Theodore A. Boutacoff, David M. Buzawa and James L. Donovan in February 1989 and is headquartered in Mountain View, CA.
